MIR1270

Across TCGA pan-cancer cohorts, MIR1270 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR1270 data layer compared with 6 for mutation status.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR1270 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR1270 expression acts as an unfavorable survival marker, although some lineages such as BLCA and OV show a favorable association.

BLCA, DLBC, and ACC are the cancer types where MIR1270 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.424	0.259	.001	88	view →
DLBC	DFS	Tertile	All	0.453	1.000	<.001	65	view →
ACC	OS	Median	III,IV	0.366	0.811	.003	60	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LIHC	OS	Quartile	All	0.559	0.725	<.001	33	view →
OV	DFS	Tertile	All	0.601	0.507	.020	28	view →
STAD	DFS	Tertile	III,IV	0.741	0.311	.008	27	view →
COAD	DFS	Tertile	III,IV	0.890	0.332	.019	27	view →
KIRC	DFS	Median	IV	0.748	0.478	.002	20	view →
UCS	OS	Tertile	IV	1.000	0.293	.035	18	view →
MESO	OS	Tertile	IV	0.852	0.324	.004	18	view →
THCA	DFS	Tertile	II,III,IV	0.884	0.990	.004	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR1270–BLCA (DFS)

Open the BLCA breakdown →